Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-499P is a pseudogene corresponding to U6 small nuclear RNA (U6 snRNA). U6 snRNA is a highly conserved non-coding RNA that functions as a core catalytic component of the spliceosome, the macromolecular complex responsible for the removal of introns from pre-mRNA in eukaryotic cells[1][3]. However, as a pseudogene, RNU6-499P does not encode a functional U6 snRNA and instead represents a transcriptionally inactive or non-functional genomic copy. Pseudogenes like RNU6-499P are generally considered non-functional, but some may be transcribed and could have roles in gene regulation such as acting as decoys for miRNAs or being sources of small RNAs[2]. There is no evidence that RNU6-499P encodes a therapeutic target, has direct biological or disease functions, or interacts with drugs. It is therefore not considered a therapeutic target, and its inclusion as one is likely incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 499, pseudogene (RNU6-499P).